Psilocybin Descheduling Update In AGGARWAL V. UNITED STATES DRUG ENFORCEMENT ADMINISTRATION, No. 22-1718 (9th Cir. 2023)

Nov 9, 2023

—

by

https://law.justia.com/cases/federal/appellate-courts/ca9/22-1718/22-1718-2023-10-27.html

Doctor Aggarwal’s latest in his ongoing struggle to remove Schedule One classification of psilocybin by the drug cartel’s biggest economic protectionists, the Drug Enforcement Administration (DEA).

Drug policy of prohibition empowers criminals. Rescheduling process disempowers them. Act accordingly.

22-1718-2023-10-27 Download

21 U.S. Code § 811(b) Accepted Medical Use IN THE UNITED STATES Controlled Substances Act Criminal Drug Enterprises Dr Aggarwal Drug Cartels Drug Enforcement Administration FDA Five Factor Test Health and Human Resources Schedule One Psilocybin Descheduling Petition Psilocybin Schedule One WeedPress

Psilocybin Descheduling Update In AGGARWAL V. UNITED STATES DRUG ENFORCEMENT ADMINISTRATION, No. 22-1718 (9th Cir. 2023)

Share this:

Comments

Leave a comment Cancel reply